Psychedelic Bulletin: MindMed to List on Nasdaq; Atai IPO Unveiled; Champignon Brands Resumes Trading Post published:April 23, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Experts Weigh in on Psilocybin vs. SSRIs; GH Research Closes $125m Round; California Decrim. Bill Passes 2nd Key Committee Post published:April 16, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: CA Decrim. Bill Passes Key Committee; MindMed Publishes MDMA Dosing Study; atai Acquires DTx Company Post published:April 9, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: UCSF Launches Psychedelics Division; New Additions to the Psychedelics ETF; Massachusetts City Decriminalizes Psychedelics Post published:April 2, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: UW-Madison Launches Psychedelic Master’s Program; COMPASS Granted 2 Patents Post published:March 26, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Australian Gov Earmarks $15m for Psychedelic Studies; Otsuka Licences R-ketamine in Japan; DC Initiative Becomes Law Post published:March 19, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Harvard Revisits Psychedelics; MindMed Attracts Strategic Investor; Psychedelics Companies Shed Cannabis Assets Post published:March 12, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Atai Scoops $157m; Efficacy of Microdosing Under Scrutiny; Bright Minds Reduces Bing Eating in Rats Post published:March 5, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Field Trip Raising $83m; NYU Langone Launches Psychedelic Medicine Center; the Many Applications of DMT Post published:February 26, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: California Bill Aims to Decriminalize Psychedelics; MindMed Acquires HealthMode; and more… Post published:February 19, 2021 Post category:Psychedelic Bulletin